The drug flibanserin, designed to treat hypoactive sexual desire disorder (HSDD), also known as chronic low libido, is on its way to be evaluated by the Food and Drug Administration.
25 Oct '21 14:25PM
21 Oct '21 20:44PM
21 Oct '21 10:44AM
15 Oct '21 15:18PM
04 Oct '21 10:20AM
04 Oct '21 09:56AM
01 Oct '21 16:31PM